CMO Suzuki Kentaro buys initial 4,000 shares of NAUT at $1.49; stock up 95.2% in 30 days despite $-13.6M net loss
Suzuki Kentaro, Chief Marketing Officer, made his first purchase of Nautilus Biotechnology shares, acquiring 4,000 shares at $1.49 on 2025-11-06, establishing a new position from zero prior holdings. The transaction occurs within a volatile price environment: the stock has appreciated 95.2% over the past 30 days and 132.8% over 90 days, yet remains 42.6% below its 52-week high of $2.89 and trades at $1.66 currently. Notably, the company reported a full-year net income of $-13.6M, indicating persistent unprofitability. The purchase timing coincides with a significant recent rally rather than accumulation during depressed valuations, warranting consideration of whether this reflects management confidence or participation in momentum-driven movement.